Glucagon-like peptide-1 (GLP-1) receptor agonists, such as tirzepatide, have shown promise not only in managing type 2 diabetes and obesity but also in reducing inflammation, a common underlying factor in various chronic diseases. This article explores the mechanisms and clinical evidence supporting the anti-inflammatory effects of these medications. Mechanisms of Anti-Inflammatory Action Clinical Evidence of […]